Drug Interactions between Allegra-D 24 Hour and Doxy 200
This report displays the potential drug interactions for the following 2 drugs:
- Allegra-D 24 Hour (fexofenadine/pseudoephedrine)
- Doxy 200 (doxycycline)
Interactions between your drugs
No interactions were found between Allegra-D 24 Hour and Doxy 200. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Allegra-D 24 Hour
- Allegra-d 24 hour is in the drug class upper respiratory combinations.
- Allegra-d 24 hour is used to treat Allergic Rhinitis.
A total of 189 drugs are known to interact with Doxy 200.
- Doxy 200 is in the following drug classes: miscellaneous antimalarials, tetracyclines.
Doxy 200 is used to treat the following conditions:
- Anthrax Prophylaxis
- Bacterial Infection
- Bullous Pemphigoid
- Chlamydia Infection
- Cutaneous Bacillus anthracis
- Epididymitis, Sexually Transmitted
- Gonococcal Infection, Uncomplicated
- Granuloma Inguinale
- Lyme Disease
- Lyme Disease, Arthritis
- Lyme Disease, Carditis
- Lyme Disease, Erythema Chronicum Migrans
- Lyme Disease, Neurologic
- Lymphogranuloma Venereum
- Malaria Prevention
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Ocular Rosacea
- Pelvic Inflammatory Disease
- Pleural Effusion
- Rabbit Fever
- Rickettsial Infection
- Skin or Soft Tissue Infection
- STD Prophylaxis
- Syphilis, Early
- Syphilis, Latent
- Tertiary Syphilis
- Upper Respiratory Tract Infection
- Urinary Tract Infection
Drug and food interactions
Applies to: Allegra-D 24 Hour (fexofenadine / pseudoephedrine)
Consuming large amounts of certain fruit juices, including grapefruit, orange and apple, may decrease the levels of fexofenadine in your body. Fexofenadine should be taken with water and refrain from drinking large amounts of grapefruit, orange, or apple juice. This will make it easier for your body to absorb the medication.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.